Concepedia

Publication | Closed Access

Treatment of Schizophrenia With Long-Acting Injectable Risperidone

DOI

287

Citations

0

References

2003

Year

W. Wolfgang Fleischhacker, Mariëlle Eerdekens, Keith Karcher, Gary Remington, Pierre‐Michel Llorca, W. Chrzanowski, S Martin
The Journal of Clinical Psychiatry

Abstract

In terms of both safety and efficacy, symptomatically stable patients with schizophrenia benefit from being switched to long-acting injectable risperidone.